Replies to post #496112 on NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

I agree Newman, but to my knowledge no acknowledgement of CRL doing the production for NWBO of the commercial product has yet to be announced. We really don't know how it will be structured. One scenario might actually have CRL paying substantial money for rights to use the FlaskWorks units, that could alleviate the need for immediate funding if it were structured that way. Of course it could easily go the other way as well with NWBO paying them up front, but CRL receiving less for each batch of vaccine they create.

Of course nothing is certain until it's announced. For all we know NWBO could be developing it's own facility for producing the vaccine here in the U.S. I don't think so, but anything is possible.

Gary

[skitahoe]

Newman, just another thought, do you believe the successful compatibility test is one that all 4 regulators are accepting, or is all we can really say is that the U.K. has accepted it. I would hope the same test was observed by all 4 regulators, but would like to see that in print to be certain.

Gary